img

Global Renal Denervation Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Renal Denervation Treatment Market Research Report 2024

Renal denervation is a catheter-based minimally-invasive procedure. It is a therapy performed by radiofrequency or ultrasound ablation for uncontrolled hypertension. 
According to MRAResearch’s new survey, global Renal Denervation Treatment market is projected to reach US$ 718.3 million in 2033, increasing from US$ 511 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Renal Denervation Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Renal Denervation Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
ReCor Medical
Boston Scientific
Cardiosonic
Medtronic
Kona medical
Mercator Medsystems
Terumo Corporation
Abbott Laboratories
Theragenics Corporation
Segment by Type
Radiofrequency
Ultrasound

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Renal Denervation Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Denervation Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Radiofrequency
1.2.3 Ultrasound
1.3 Market by Application
1.3.1 Global Renal Denervation Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Denervation Treatment Market Perspective (2018-2033)
2.2 Renal Denervation Treatment Growth Trends by Region
2.2.1 Global Renal Denervation Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Renal Denervation Treatment Historic Market Size by Region (2018-2023)
2.2.3 Renal Denervation Treatment Forecasted Market Size by Region (2024-2033)
2.3 Renal Denervation Treatment Market Dynamics
2.3.1 Renal Denervation Treatment Industry Trends
2.3.2 Renal Denervation Treatment Market Drivers
2.3.3 Renal Denervation Treatment Market Challenges
2.3.4 Renal Denervation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Denervation Treatment Players by Revenue
3.1.1 Global Top Renal Denervation Treatment Players by Revenue (2018-2023)
3.1.2 Global Renal Denervation Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Renal Denervation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Renal Denervation Treatment Revenue
3.4 Global Renal Denervation Treatment Market Concentration Ratio
3.4.1 Global Renal Denervation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Denervation Treatment Revenue in 2022
3.5 Renal Denervation Treatment Key Players Head office and Area Served
3.6 Key Players Renal Denervation Treatment Product Solution and Service
3.7 Date of Enter into Renal Denervation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Denervation Treatment Breakdown Data by Type
4.1 Global Renal Denervation Treatment Historic Market Size by Type (2018-2023)
4.2 Global Renal Denervation Treatment Forecasted Market Size by Type (2024-2033)
5 Renal Denervation Treatment Breakdown Data by Application
5.1 Global Renal Denervation Treatment Historic Market Size by Application (2018-2023)
5.2 Global Renal Denervation Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Renal Denervation Treatment Market Size (2018-2033)
6.2 North America Renal Denervation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Renal Denervation Treatment Market Size by Country (2018-2023)
6.4 North America Renal Denervation Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Denervation Treatment Market Size (2018-2033)
7.2 Europe Renal Denervation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Renal Denervation Treatment Market Size by Country (2018-2023)
7.4 Europe Renal Denervation Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Denervation Treatment Market Size (2018-2033)
8.2 Asia-Pacific Renal Denervation Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Renal Denervation Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Renal Denervation Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Denervation Treatment Market Size (2018-2033)
9.2 Latin America Renal Denervation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Renal Denervation Treatment Market Size by Country (2018-2023)
9.4 Latin America Renal Denervation Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Denervation Treatment Market Size (2018-2033)
10.2 Middle East & Africa Renal Denervation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Renal Denervation Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Renal Denervation Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Renal Denervation Treatment Introduction
11.1.4 Abbott Revenue in Renal Denervation Treatment Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 ReCor Medical
11.2.1 ReCor Medical Company Detail
11.2.2 ReCor Medical Business Overview
11.2.3 ReCor Medical Renal Denervation Treatment Introduction
11.2.4 ReCor Medical Revenue in Renal Denervation Treatment Business (2018-2023)
11.2.5 ReCor Medical Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Detail
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Renal Denervation Treatment Introduction
11.3.4 Boston Scientific Revenue in Renal Denervation Treatment Business (2018-2023)
11.3.5 Boston Scientific Recent Development
11.4 Cardiosonic
11.4.1 Cardiosonic Company Detail
11.4.2 Cardiosonic Business Overview
11.4.3 Cardiosonic Renal Denervation Treatment Introduction
11.4.4 Cardiosonic Revenue in Renal Denervation Treatment Business (2018-2023)
11.4.5 Cardiosonic Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Renal Denervation Treatment Introduction
11.5.4 Medtronic Revenue in Renal Denervation Treatment Business (2018-2023)
11.5.5 Medtronic Recent Development
11.6 Kona medical
11.6.1 Kona medical Company Detail
11.6.2 Kona medical Business Overview
11.6.3 Kona medical Renal Denervation Treatment Introduction
11.6.4 Kona medical Revenue in Renal Denervation Treatment Business (2018-2023)
11.6.5 Kona medical Recent Development
11.7 Mercator Medsystems
11.7.1 Mercator Medsystems Company Detail
11.7.2 Mercator Medsystems Business Overview
11.7.3 Mercator Medsystems Renal Denervation Treatment Introduction
11.7.4 Mercator Medsystems Revenue in Renal Denervation Treatment Business (2018-2023)
11.7.5 Mercator Medsystems Recent Development
11.8 Terumo Corporation
11.8.1 Terumo Corporation Company Detail
11.8.2 Terumo Corporation Business Overview
11.8.3 Terumo Corporation Renal Denervation Treatment Introduction
11.8.4 Terumo Corporation Revenue in Renal Denervation Treatment Business (2018-2023)
11.8.5 Terumo Corporation Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Detail
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Renal Denervation Treatment Introduction
11.9.4 Abbott Laboratories Revenue in Renal Denervation Treatment Business (2018-2023)
11.9.5 Abbott Laboratories Recent Development
11.10 Theragenics Corporation
11.10.1 Theragenics Corporation Company Detail
11.10.2 Theragenics Corporation Business Overview
11.10.3 Theragenics Corporation Renal Denervation Treatment Introduction
11.10.4 Theragenics Corporation Revenue in Renal Denervation Treatment Business (2018-2023)
11.10.5 Theragenics Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Renal Denervation Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Radiofrequency
Table 3. Key Players of Ultrasound
Table 4. Global Renal Denervation Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Renal Denervation Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Renal Denervation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Renal Denervation Treatment Market Share by Region (2018-2023)
Table 8. Global Renal Denervation Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Renal Denervation Treatment Market Share by Region (2024-2033)
Table 10. Renal Denervation Treatment Market Trends
Table 11. Renal Denervation Treatment Market Drivers
Table 12. Renal Denervation Treatment Market Challenges
Table 13. Renal Denervation Treatment Market Restraints
Table 14. Global Renal Denervation Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Renal Denervation Treatment Market Share by Players (2018-2023)
Table 16. Global Top Renal Denervation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation Treatment as of 2022)
Table 17. Ranking of Global Top Renal Denervation Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Renal Denervation Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Renal Denervation Treatment Product Solution and Service
Table 21. Date of Enter into Renal Denervation Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Renal Denervation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Renal Denervation Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Renal Denervation Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Renal Denervation Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Renal Denervation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Renal Denervation Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Renal Denervation Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Renal Denervation Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Renal Denervation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Renal Denervation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Renal Denervation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Renal Denervation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Renal Denervation Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Renal Denervation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Renal Denervation Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Renal Denervation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Renal Denervation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Renal Denervation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Renal Denervation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Renal Denervation Treatment Product
Table 49. Abbott Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. ReCor Medical Company Detail
Table 52. ReCor Medical Business Overview
Table 53. ReCor Medical Renal Denervation Treatment Product
Table 54. ReCor Medical Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 55. ReCor Medical Recent Development
Table 56. Boston Scientific Company Detail
Table 57. Boston Scientific Business Overview
Table 58. Boston Scientific Renal Denervation Treatment Product
Table 59. Boston Scientific Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 60. Boston Scientific Recent Development
Table 61. Cardiosonic Company Detail
Table 62. Cardiosonic Business Overview
Table 63. Cardiosonic Renal Denervation Treatment Product
Table 64. Cardiosonic Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 65. Cardiosonic Recent Development
Table 66. Medtronic Company Detail
Table 67. Medtronic Business Overview
Table 68. Medtronic Renal Denervation Treatment Product
Table 69. Medtronic Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 70. Medtronic Recent Development
Table 71. Kona medical Company Detail
Table 72. Kona medical Business Overview
Table 73. Kona medical Renal Denervation Treatment Product
Table 74. Kona medical Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 75. Kona medical Recent Development
Table 76. Mercator Medsystems Company Detail
Table 77. Mercator Medsystems Business Overview
Table 78. Mercator Medsystems Renal Denervation Treatment Product
Table 79. Mercator Medsystems Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 80. Mercator Medsystems Recent Development
Table 81. Terumo Corporation Company Detail
Table 82. Terumo Corporation Business Overview
Table 83. Terumo Corporation Renal Denervation Treatment Product
Table 84. Terumo Corporation Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 85. Terumo Corporation Recent Development
Table 86. Abbott Laboratories Company Detail
Table 87. Abbott Laboratories Business Overview
Table 88. Abbott Laboratories Renal Denervation Treatment Product
Table 89. Abbott Laboratories Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 90. Abbott Laboratories Recent Development
Table 91. Theragenics Corporation Company Detail
Table 92. Theragenics Corporation Business Overview
Table 93. Theragenics Corporation Renal Denervation Treatment Product
Table 94. Theragenics Corporation Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 95. Theragenics Corporation Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Denervation Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Renal Denervation Treatment Market Share by Type: 2022 VS 2033
Figure 3. Radiofrequency Features
Figure 4. Ultrasound Features
Figure 5. Global Renal Denervation Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Renal Denervation Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Renal Denervation Treatment Report Years Considered
Figure 11. Global Renal Denervation Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Renal Denervation Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Renal Denervation Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Renal Denervation Treatment Market Share by Players in 2022
Figure 15. Global Top Renal Denervation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Renal Denervation Treatment Revenue in 2022
Figure 17. North America Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Renal Denervation Treatment Market Share by Country (2018-2033)
Figure 19. United States Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Renal Denervation Treatment Market Share by Country (2018-2033)
Figure 23. Germany Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Renal Denervation Treatment Market Share by Region (2018-2033)
Figure 31. China Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Renal Denervation Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Renal Denervation Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Abbott Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 46. ReCor Medical Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 47. Boston Scientific Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 48. Cardiosonic Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 49. Medtronic Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 50. Kona medical Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 51. Mercator Medsystems Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 52. Terumo Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 53. Abbott Laboratories Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 54. Theragenics Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed